cyclosporine has been researched along with Diabetes Mellitus, Adult-Onset in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (13.95) | 18.2507 |
2000's | 14 (32.56) | 29.6817 |
2010's | 20 (46.51) | 24.3611 |
2020's | 3 (6.98) | 2.80 |
Authors | Studies |
---|---|
Hunter, H; Middleton, D; Mulholland, O | 1 |
Araki, M; Hioki, T; Kamiya, H; Kitajima, Y | 1 |
Chen, F; Wang, P; Zhang, X | 1 |
Han, DJ; Jung, CH; Jung, JH; Kim, DH; Kim, YH; Ko, Y; Kwon, H; Lim, SJ; Mun, S; Shin, S | 1 |
Acebes, A; Brito-Casillas, Y; Cuesto, G; De Vries, APJ; Porrini, E; Rodriguez-Rodriguez, AE; Salido, E; Torres, A; Triñanes, J; Wagner, A | 1 |
Kälble, F; Morath, C; Schaier, M; Schwenger, V; Seckinger, J; Sommerer, C; Zeier, M | 1 |
Quack, I; Rump, LC; Schmitz, M; Tillmann, FP | 1 |
Bradley, JL; Dana, R; Evans, AM; Guerin, A; Pivneva, I; Stillman, IÖ | 1 |
Chung, C; Hamann, CR; Kaffenberger, BH | 1 |
Gola, J; Grabarek, B; Michalska-Bańkowska, A; Wcisło-Dziadecka, D | 1 |
Hilbrands, LB; van den Hoogen, MW; van der Hoeven, AM | 1 |
Jiang, M; Li, F; Li, K; Luo, L; Meng, Q; Sun, C; Wang, C | 1 |
Croy, R; Dhadda, S; First, MR; Fitzsimmons, WE; Holman, J | 1 |
Narayan, G; Sahay, M; Sahay, RK | 1 |
Azzi, JR; Mallat, SG; Sayegh, MH | 1 |
Bo, Q; Brass, C; Griffel, L; Orsenigo, R; Wang, J | 1 |
Handisurya, A; Herkner, H; Kautzky-Willer, A; Kerscher, C; Mandorfer, M; Pacini, G; Payer, BA; Reiberger, T; Säemann, M; Schmidt, A; Tura, A; Werzowa, J; Winnicki, W | 1 |
Abbasi, MA; Abdi, E; Ataipoor, Y; Ebrahimzadeh, K; Eris, S; Ghods, AJ; Heidari, H; Nejadgashti, H; Ossareh, S; Prooshaninia, F; Saheb-Jamii, H; Savaj, S | 1 |
Alavian, SM | 1 |
Ozer, JS | 1 |
Bai, JP; Burckart, GJ; Lesko, LJ | 1 |
Anglicheau, D; Beaune, P; Bouvier, N; Legendre, C; Pallet, N; Thervet, E | 1 |
Cabibi, D; Carroccio, A; D'Alcamo, A; Fede, GD; Mansueto, P; Patti, AM; Pisciotta, G; Rini, GB; Seidita, A; Sprini, D; Tomasello, G | 1 |
Azón, A; Gil, I; Grau, C; Hidalgo, I; Martinez, F | 1 |
Bjerre, M; Carstens, J; Juhl, C; Jørgensen, KA; Møller, N; Ozbay, LA; Rungby, J | 1 |
Evans, S; Goldsmith, D; Gordon, I; Maclean, D; Michael, R; Taylor, J; Wells, H | 1 |
Myhr, KM; Njølstad, PR; Nyland, H; Sagen, J; Søvik, O | 1 |
Aho, H; Itälä, M; Remes, K | 1 |
Baldwin, D; Villanueva, G | 1 |
Bernard, S; Boillot, O; Bouffard, Y; Dumortier, J | 1 |
Caringella, DA; Colella, V; Dammacco, A; Depalo, T; Di Paolo, S; Giordano, M; Grandaliano, G; Teutonico, A; Torelli, C | 1 |
Bajema, IM; Bemelman, FJ; Cremers, S; de Fijter, JW; Eikmans, M; Florquin, S; Mallat, MJ; Rowshani, AT; Scholten, EM; Surachno, J; ten Berge, IJ; van Kan, E | 1 |
el Mansour, A; Gouin, E; Martignat, L; Maugendre, S; Saï, P; Senecat, O | 1 |
Akiyama, K; Hayashi, Y; Kushiro, M; Makino, H; Matsuda, M; Ota, Z; Shikata, K; Shikata, Y; Sugimoto, H | 1 |
Hikichi, N; Iizuka, Y; Murata, R; Ogata, M; Suzuki, S; Toyota, T; Uchimura, T | 1 |
Gentile, S; Torella, R; Turco, S | 1 |
Han, DJ; Jang, HJ; Kim, SC | 1 |
Dequiedt, P; Fontaine, P; Guillem, P; Pruvot, FR; Vlaeminck-Guillem, V | 1 |
Moreno, AJ; Oliveira, PJ; Palmeira, CM; Rolo, AP; Santos, MS; Seiça, R | 1 |
al Ayafi, H; al Jumah, M; Awada, A; Dehoux, E | 1 |
Fukatsu, A; Kita, T; Makibayashi, K | 1 |
Arap, S; Fonseca, JA; Ianhez, LE; Sabbaga, E | 1 |
Koselj, KM; Koselj, M; Kveder, R | 1 |
4 review(s) available for cyclosporine and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
A guidance for renal biomarker lead optimization and use in translational pharmacodynamics.
Topics: Albumins; Animals; Autoimmune Diseases; Bile Acids and Salts; Biomarkers, Pharmacological; Cathepsin B; Cyclosporine; Cystatin C; Cysteine; Diabetes Mellitus, Type 2; Drug Approval; Drug Evaluation, Preclinical; Humans; Immunosuppressive Agents; Kidney; Leukotrienes; Models, Animal; Translational Research, Biomedical | 2010 |
[Involvement of endoplasmic reticulum stress in solid organ transplantation].
Topics: Animals; Apoptosis; Cyclosporine; Diabetes Mellitus, Type 2; Drug Delivery Systems; Endoplasmic Reticulum; Graft Survival; Humans; Insulin Resistance; Islets of Langerhans; Kidney Transplantation; Liver Transplantation; Mice; Organ Preservation; Postoperative Complications; Reperfusion Injury; Tacrolimus; Transplantation; Transplantation, Homologous; Unfolded Protein Response | 2010 |
Malignant tumor-like gastric lesion due to Candida albicans in a diabetic patient treated with cyclosporin: a case report and review of the literature.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cyclosporine; Diabetes Mellitus, Type 2; Female; Humans; Itraconazole; Middle Aged; Stomach Ulcer | 2012 |
Reduced-intensity conditioning and blood stem cell transplantation from an HLA-identical sibling for severe aplastic anaemia: two patients with successful engraftment but a fatal post-transplant lymphoproliferative disorder in the other.
Topics: Adrenal Cortex Hormones; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Type 2; Drug Resistance; Epstein-Barr Virus Infections; Fatal Outcome; Histocompatibility; Humans; Immunosuppressive Agents; Lymphoma, B-Cell; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Siblings; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Tumor Virus Infections | 2004 |
4 trial(s) available for cyclosporine and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.
Topics: Adult; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 2; Glomerular Filtration Rate; Glucose Tolerance Test; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Insulin; Insulin Resistance; Kidney Transplantation; Liver; Middle Aged; Prospective Studies; Risk Factors; RNA, Viral; Tacrolimus; Transplant Recipients | 2016 |
The impact of calcineurin inhibitors on insulin sensitivity and insulin secretion: a randomized crossover trial in uraemic patients.
Topics: Body Mass Index; Calcineurin; Cross-Over Studies; Cyclosporine; Denmark; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Tacrolimus | 2012 |
Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function.
Topics: Adult; Area Under Curve; Biopsy; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus, Type 2; Female; Fibrosis; Graft Rejection; Graft Survival; Humans; Kidney; Kidney Transplantation; Male; Middle Aged; Tacrolimus | 2006 |
Renal transplantation in diabetic patients: a survey of 100 cases.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Follow-Up Studies; Graft Survival; Humans; Kidney Transplantation; Male; Prednisone; Retrospective Studies; Survival Analysis; Time Factors | 1992 |
35 other study(ies) available for cyclosporine and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Negative-pressure wound therapy as an adjunct to treating pyoderma gangrenosum.
Topics: Cyclosporine; Diabetes Mellitus, Type 2; Female; Humans; Middle Aged; Negative-Pressure Wound Therapy; Prednisolone; Pyoderma Gangrenosum | 2022 |
Annular elastolytic giant cell granuloma associated with diabetes mellitus: a case treated with a combination of low-dose cyclosporine and dapsone.
Topics: Aged, 80 and over; Anti-Infective Agents; Cyclosporine; Dapsone; Dermatologic Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Granuloma Annulare; Granuloma, Giant Cell; Humans; Male | 2019 |
Cyclosporine-a attenuates retinal inflammation by inhibiting HMGB-1 formation in rats with type 2 diabetes mellitus.
Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Retinopathy; HMGB1 Protein; Interleukin-1beta; Intravitreal Injections; Male; Rats, Sprague-Dawley; Retina; Tumor Necrosis Factor-alpha | 2020 |
Lack of Improvement in Insulin Sensitivity After Pancreas Transplantation in Recipients With a High Level of Calcineurin Inhibitors.
Topics: Adult; Blood Glucose; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Kaplan-Meier Estimate; Male; Middle Aged; Pancreas Transplantation; Tacrolimus | 2021 |
Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells.
Topics: Animals; Calcineurin; Cyclosporine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Immunosuppressive Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Nerve Tissue Proteins; NFATC Transcription Factors; Obesity; Rats; Rats, Zucker; Tacrolimus; Thinness | 2017 |
Switch to an everolimus-facilitated cyclosporine A sparing immunosuppression improves glycemic control in selected kidney transplant recipients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 2; Everolimus; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prediabetic State; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
Impact of low-dose steroids on HbA1c levels and development of pre-diabetes and NODAT in non-diabetic renal transplant recipients on long-term follow-up.
Topics: Adult; Age Factors; Aged; Body Mass Index; Cyclosporine; Diabetes Mellitus, Type 2; Female; Glucocorticoids; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Prediabetic State; Prednisolone; Risk Factors; Tacrolimus; Time Factors; Transplant Recipients | 2018 |
Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Cataract; Comorbidity; Cyclosporine; Databases, Factual; Diabetes Mellitus, Type 2; Drug Prescriptions; Dry Eye Syndromes; Emulsions; Female; Glaucoma; Humans; Hypertension; Immunosuppressive Agents; International Classification of Diseases; Male; Middle Aged; Military Personnel; Ophthalmic Solutions; Retrospective Studies; Thyroid Diseases; United States | 2019 |
Pyoderma gangrenosum associated with dulaglutide therapy.
Topics: Adalimumab; Biopsy; Cyclosporine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucagon-Like Peptides; Humans; Hypoglycemic Agents; Immunoglobulin Fc Fragments; Injections, Intralesional; Middle Aged; Pyoderma Gangrenosum; Recombinant Fusion Proteins; Skin; Treatment Outcome; Triamcinolone | 2019 |
The impact of diabetes and metabolic syndromes to the effectiveness of cyclosporine a pharmacotherapy in psoriatic patients.
Topics: Cyclosporine; Diabetes Mellitus, Type 2; Humans; Metabolic Syndrome; Psoriasis | 2019 |
Insulin requirement after a renal transplant in patients with type 2 diabetes: the choice of calcineurin inhibitors.
Topics: Adrenal Cortex Hormones; Aged; Blood Glucose; Calcineurin Inhibitors; Case-Control Studies; Cyclosporine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Tacrolimus; Time Factors; Treatment Outcome | 2013 |
Cyclosporin A attenuates weight gain and improves glucose tolerance in diet-induced obese mice.
Topics: Adipocytes; Adipose Tissue, White; Animals; Blood Glucose; Cell Differentiation; Cyclosporine; Diabetes Mellitus, Type 2; Eating; fas Receptor; Glucose; Glucose-6-Phosphatase; Immunosuppressive Agents; Inflammation; Insulin Resistance; Interleukin-12; Interleukin-1beta; Interleukin-2; JNK Mitogen-Activated Protein Kinases; Lipid Metabolism; Mice; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Protein Serine-Threonine Kinases; Signal Transduction; Stearoyl-CoA Desaturase; Transcription Factors; Tumor Necrosis Factor-alpha; Weight Gain | 2013 |
New-onset diabetes after transplantation (NODAT): an evaluation of definitions in clinical trials.
Topics: Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus, Type 2; Female; Graft Survival; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Incidence; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Postoperative Complications; Prevalence; Registries; Risk Factors; Tacrolimus; Terminology as Topic | 2013 |
New-onset diabetes after transplantation--role of oral glucose tolerance test for diagnosis and study of risk factors.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Immunosuppressive Agents; Insulin Resistance; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Risk Factors; Transplantation, Homologous; Young Adult | 2013 |
Calcineurin inhibitors: 40 years later, can't live without ...
Topics: Animals; Autoimmune Diseases; Calcineurin; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Drug Therapy, Combination; Forecasting; Graft Rejection; History, 20th Century; History, 21st Century; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Lymphocyte Activation; Meta-Analysis as Topic; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; T-Lymphocytes; Tacrolimus | 2013 |
Glucose abnormalities in Asian patients with chronic hepatitis C.
Topics: Adult; Age Factors; Antiviral Agents; Asian People; Blood Glucose; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclosporine; Diabetes Mellitus, Type 2; Female; Hepatitis C, Chronic; Humans; Interferons; Logistic Models; Male; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Ribavirin; Risk Factors; Sex Factors; Treatment Outcome | 2015 |
Posttransplant diabetes mellitus in kidney allograft recipients at Shaheed Hasheminejad Hospital.
Topics: Adult; Age Factors; Cyclosporine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Hospitals, University; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Prospective Studies | 2008 |
Re: posttransplant diabetes mellitus in kidney allograft recipients at Shaheed Hasheminejad Hospital.
Topics: Cyclosporine; Diabetes Mellitus, Type 2; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation | 2008 |
Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors.
Topics: Biomarkers, Pharmacological; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus, Type 2; Drug Discovery; Genotype; Humans; Hypertension; Immunosuppressive Agents; Polymorphism, Genetic; Precision Medicine; Renal Insufficiency; Risk Factors; Tacrolimus | 2010 |
[Follicular lymphoma with paraneoplastic autoimmune multiorgan syndrome].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Cheilitis; Conjunctivitis; Corneal Ulcer; Cyclophosphamide; Cyclosporine; Diabetes Mellitus, Type 2; Glossitis; Humans; Keratinocytes; Keratosis; Lymphoma, Follicular; Male; Methylprednisolone; Paraneoplastic Syndromes; Pemphigus; Prednisone; Remission Induction; Rituximab; Skin Ulcer; Stroke; Vincristine | 2012 |
Drug interaction in a renal transplant patient: cyclosporin-Neoral and orlistat.
Topics: Administration, Oral; Anti-Obesity Agents; Cyclosporine; Diabetes Mellitus, Type 2; Drug Interactions; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Lactones; Male; Middle Aged; Obesity; Orlistat | 2003 |
Contributions to the MODY5 phenotype.
Topics: Abnormalities, Multiple; Adult; Central Nervous System Diseases; Cyclosporine; Dental Enamel; Diabetes Mellitus, Type 2; Female; Genitalia, Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Phenotype; Syndrome | 2002 |
Rosiglitazone therapy of posttransplant diabetes mellitus.
Topics: Adult; Aged; Cyclosporine; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Insulin; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Organ Transplantation; PPAR gamma; Prospective Studies; Rosiglitazone; Tacrolimus; Thiazolidinediones | 2005 |
Conversion from tacrolimus to cyclosporine in liver transplanted patients with diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Cyclosporine; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Immunosuppression Therapy; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus; Treatment Outcome | 2006 |
A study on glucose metabolism in a small cohort of children and adolescents with kidney transplant.
Topics: Adolescent; Blood Glucose; Body Mass Index; Child; Cohort Studies; Cyclosporine; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Insulin; Kidney Transplantation; Male; Tacrolimus | 2006 |
Cyclosporin depresses pancreatic islet expression of antigens for islet cell autoantibodies in non obese diabetic mice.
Topics: Animals; Antigens, CD; Autoantibodies; Autoantigens; Cell Size; Cyclosporine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Immunohistochemistry; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Inbred NOD; T-Lymphocyte Subsets | 1996 |
A case of early-stage diabetic nephropathy complicated by minimal change nephrotic syndrome treated with cyclosporin A.
Topics: Cyclosporine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Immunosuppressive Agents; Kidney; Male; Middle Aged; Nephrosis, Lipoid | 1997 |
Effect of non-insulin dependent diabetes on cyclosporin A disposition in Goto-Kakizaki (GK) rats.
Topics: Administration, Oral; Animals; Biological Availability; Cyclosporine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gastric Emptying; Gastrointestinal Transit; Immunosuppressive Agents; Injections, Intravenous; Lymphatic System; Rats; Rats, Inbred Strains; Rats, Wistar | 1997 |
Diabetes mellitus after liver transplantation: a possible relation with the nutritional status.
Topics: Albuminuria; Bilirubin; Blood Glucose; Blood Proteins; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 2; Fibrosis; Glucocorticoids; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Liver Transplantation; Male; Middle Aged; Nutritional Status; Prednisone; Radioimmunoassay; Triglycerides; Uric Acid | 1998 |
Comparison of pancreas transplantation outcome between the cyclosporine and tacrolimus eras.
Topics: Adolescent; Adult; Chronic Disease; Cyclosporine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Male; Middle Aged; Pancreas Transplantation; Pancreatitis; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors | 2000 |
Liver transplantation eliminates insulin needs of a diabetic patient.
Topics: Aged; Blood Glucose; Cyclosporine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Female; Glomerulonephritis; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Insulin; Kidney Failure, Chronic; Liver Transplantation; Middle Aged; Postoperative Period | 2000 |
Decreased susceptibility of heart mitochondria from diabetic GK rats to mitochondrial permeability transition induced by calcium phosphate.
Topics: Animals; Calcium; Calcium Phosphates; Cell Membrane Permeability; Cyclosporine; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Fluorescent Dyes; Male; Mitochondria, Heart; Myocardium; Organic Chemicals; Rats; Rats, Mutant Strains; Rats, Wistar; Subcellular Fractions | 2001 |
[Rapidly evolving diabetic mononeuritis multiplex. Favorable outcome after immunosuppressive treatment].
Topics: Adrenal Cortex Hormones; Cranial Nerve Diseases; Cyclosporine; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Drug Therapy, Combination; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Mononeuropathies; Treatment Outcome | 2001 |
[Complete remission of minimal change nephrotic syndrome with type 2 diabetes mellitus treated by microemulsion formulation of cyclosporin and fluvastatin].
Topics: Anticholesteremic Agents; Cyclosporine; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Emulsions; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hyperlipidemias; Immunosuppressive Agents; Indoles; Male; Middle Aged; Nephrosis, Lipoid; Remission Induction; Treatment Outcome | 2002 |
Posttransplant diabetes mellitus in renal allograft recipients.
Topics: Adolescent; Adult; Cadaver; Cyclosporine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Insulin; Kidney Transplantation; Male; Middle Aged; Postoperative Complications | 1992 |